Genefirst

Biotechnology Research · 11 Employees
Phone Number: 4401865407400
Email Address: info@genefirst.com
  • Overview
  • Employees
Access 15 Verified Employees Profiles for GenefirstUnlock Free Contacts Now
About
We are a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine. Our ethos is to offer robust easy-to-use, sensitive, and affordable molecular diagnostics technologies and products to researchers, clinicians and drug companies to enable accurate diagnosis and the delivery of safe and effective medicines. Our patented technologies allow for simultaneous detection of multiple targets in one reaction. If you have a project or collaboration in mind, we'd love to hear from you! Do you have a requirement for detecting multiple targets? Are you working with bacteria, viruses or fungus? We can help you achieve what you need with our dedicated team of experts. Drop us a line here or email us at info@genefirst.com
Year Founded
2011
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
Abingdon Science Park Unit 2 The Quadrant Abingdon, Oxfordshire OX14 3YS, GB
Keywords
Molecular diagnosticsMultiplex pathogen detectionAccurate multiplex mutation detectionHigh sensitivity pathogen detectioncancer researchand Next Generation Sequencing
Location
  • Abingdon Science Park Unit 2 The Quadrant Abingdon, Oxfordshire OX14 3YS, GB

Email Formats

Sign up for free credits and discover verified email addresses of Genefirst
FormatExamples
first + last
andywarhol@genefirst.com
first_initial + last
awarhol@genefirst.com
first + last_initial
andyw@genefirst.com
first
andy@genefirst.com
last
warhol@genefirst.com
Get Verified Emails for 15 Genefirst Employees

Frequently Asked Questions

Learn More about Genefirst

Similar Companies

Biotechnology Research

Get key business info for Genefirst and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.